AXGN
Price
$17.16
Change
-$0.22 (-1.27%)
Updated
Sep 25, 03:16 PM (EDT)
Capitalization
800.16M
47 days until earnings call
GMED
Price
$55.13
Change
-$0.17 (-0.31%)
Updated
Sep 25, 03:40 PM (EDT)
Capitalization
7.47B
47 days until earnings call
Interact to see
Advertisement

AXGN vs GMED

Header iconAXGN vs GMED Comparison
Open Charts AXGN vs GMEDBanner chart's image
Axogen
Price$17.16
Change-$0.22 (-1.27%)
Volume$550
Capitalization800.16M
Globus Medical
Price$55.13
Change-$0.17 (-0.31%)
Volume$300
Capitalization7.47B
AXGN vs GMED Comparison Chart in %
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. GMED commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and GMED is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (AXGN: $17.39 vs. GMED: $55.30)
Brand notoriety: AXGN and GMED are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AXGN: 54% vs. GMED: 94%
Market capitalization -- AXGN: $800.16M vs. GMED: $7.47B
AXGN [@Medical/Nursing Services] is valued at $800.16M. GMED’s [@Medical/Nursing Services] market capitalization is $7.47B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.03B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 0 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • GMED’s FA Score: 0 green, 5 red.
According to our system of comparison, AXGN is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 4 TA indicator(s) are bullish while GMED’s TA Score has 3 bullish TA indicator(s).

  • AXGN’s TA Score: 4 bullish, 3 bearish.
  • GMED’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AXGN is a better buy in the short-term than GMED.

Price Growth

AXGN (@Medical/Nursing Services) experienced а +3.39% price change this week, while GMED (@Medical/Nursing Services) price change was -1.64% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.13%. For the same industry, the average monthly price growth was +3.01%, and the average quarterly price growth was +9.53%.

Reported Earning Dates

AXGN is expected to report earnings on Nov 11, 2025.

GMED is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.13% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.47B) has a higher market cap than AXGN($800M). AXGN YTD gains are higher at: 5.522 vs. GMED (-33.140). GMED has higher annual earnings (EBITDA): 620M vs. AXGN (10.8M). GMED has more cash in the bank: 229M vs. AXGN (29.9M). AXGN has less debt than GMED: AXGN (68.2M) vs GMED (121M). GMED has higher revenues than AXGN: GMED (2.63B) vs AXGN (203M).
AXGNGMEDAXGN / GMED
Capitalization800M7.47B11%
EBITDA10.8M620M2%
Gain YTD5.522-33.140-17%
P/E RatioN/A21.43-
Revenue203M2.63B8%
Total Cash29.9M229M13%
Total Debt68.2M121M56%
FUNDAMENTALS RATINGS
AXGN vs GMED: Fundamental Ratings
AXGN
GMED
OUTLOOK RATING
1..100
6453
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
9376
PRICE GROWTH RATING
1..100
4282
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (42) in the Medical Specialties industry is in the same range as GMED (73). This means that AXGN’s stock grew similarly to GMED’s over the last 12 months.

AXGN's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as GMED (100). This means that AXGN’s stock grew similarly to GMED’s over the last 12 months.

GMED's SMR Rating (76) in the Medical Specialties industry is in the same range as AXGN (93). This means that GMED’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for GMED (82). This means that AXGN’s stock grew somewhat faster than GMED’s over the last 12 months.

AXGN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as GMED (100). This means that AXGN’s stock grew similarly to GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNGMED
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 21 days ago
66%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARCM100.45N/A
N/A
Arrow Reserve Capital Management ETF
LFBB168.12N/A
N/A
LifeX 2063 Longevity Income ETF
PAUG42.37-0.01
-0.04%
Innovator U.S. Equity Power BufferETFAug
ILOW42.10-0.19
-0.44%
AB Active ETFs Inc.
FLBR19.07-0.18
-0.92%
Franklin FTSE Brazil ETF

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with VMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+0.52%
VMD - AXGN
36%
Loosely correlated
+0.44%
XRAY - AXGN
33%
Poorly correlated
-0.69%
GMED - AXGN
32%
Poorly correlated
-2.56%
CLPT - AXGN
32%
Poorly correlated
+58.55%
IART - AXGN
31%
Poorly correlated
-0.43%
More

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-2.56%
VREX - GMED
58%
Loosely correlated
+0.91%
CTKB - GMED
51%
Loosely correlated
-8.09%
CVRX - GMED
49%
Loosely correlated
+0.13%
ITGR - GMED
45%
Loosely correlated
-0.18%
TMCI - GMED
44%
Loosely correlated
-0.29%
More